Physician

John Otis Waits, M.D.

According to 2025 Medicare claims, John Waits, M.D. (NPI: 1396779161) practices general surgery in the Tuscaloosa, AL market, with the plurality of this provider's patient population coming from Tuscaloosa, AL. This provider's primary affiliated billing organization is DRUID CITY INFUSION CLINICS LLC (NPI: 1538634191; TIN: 850868600) and primary practice location at 35406-1833. Waits is affiliated with the Aledade A3047 MS MSSP Enhanced (ACO ID: A3047), participating under the MSSP model.

Waits' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 112 traditional Medicare patients, billed 73,289 HCPCS/CPT codes, and received $1,062,515 in Medicare payments. The top billing code was 11044 (Removal of bone, 20.0 sq cm or less). Part D data shows 452 prescription claims across 102 beneficiaries totaling $310,795 in drug costs, led by Dalvance (Dalbavancin Hcl). DME data shows 12 claims. Open Payments data shows 8 records totaling $544. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $348,941 to $1,062,515. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $60,996 to $11,939.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	395	4,781	$348,941
2016	376	4,227	$272,840
2017	374	3,557	$230,805
2018	314	6,329	$534,323
2019	310	24,876	$498,300
2020	219	85,621	$961,210
2021	223	91,584	$945,575
2022	162	71,099	$696,548
2023	137	65,747	$650,783
2024	112	73,289	$1,062,515

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	105	273	$13,116
2016	127	412	$34,365
2017	185	1,506	$218,010
2018	187	742	$431,009
2019	152	485	$401,463
2020	126	676	$378,564
2021	121	986	$477,836
2022	123	515	$281,261
2023	111	592	$323,921
2024	102	452	$310,795

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	85	223	$58,269
2016	187	281	$39,583
2017	114	290	$73,115
2018	146	338	$60,635
2019	130	205	$31,916
2020	127	282	$33,854
2021	29	185	$19,359
2022	47	98	$5,651
2023	65	225	$44,663
2024	N/R	12	$59

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
11044	Removal of bone, 20.0 sq cm or less	15	34	$151
11043	Removal of muscle and/or tissue, 20.0 sq cm or less	28	99	$102
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	13	13	$97
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	16	124	$43
11042	Removal of skin and tissue, 20.0 sq cm or less	36	153	$37

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dalvance	Dalbavancin Hcl	48	332	$248,367
Daptomycin	Daptomycin	42	281	$44,534
Ceftriaxone	Ceftriaxone Sodium	27	183	$4,946
Gentamicin Sulfate	Gentamicin Sulfate	21	314	$752
Doxycycline Hyclate	Doxycycline Hyclate	37	662	$701

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A6216	Gauze, non-impregnated, non-sterile, pad size 16 sq. in. or less, without adhesive border, each dressing	N	N/R	12	$59

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	8	$544	La Jolla Pharmaceutical Company
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for John Otis Waits, M.D.?

Tedicare shows public-source Medicare data for John Otis Waits, M.D. (NPI 1396779161), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John Otis Waits, M.D. have ACO affiliation data?

John Otis Waits, M.D. is shown with ACO affiliation data for Aledade A3047 MS MSSP Enhanced (MSSP, ACO ID A3047).

What billing organization is linked to John Otis Waits, M.D.?

John Otis Waits, M.D. is linked to DRUID CITY INFUSION CLINICS LLC (billing NPI 1538634191) in the available physician profile data.

Does John Otis Waits, M.D. have Open Payments data?

John Otis Waits, M.D. has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.